Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 670, Issue 1-2, 2009, Pages 74-78

  Shah, Parag P ^a   Saurabh, Kumar ^a   Pant, Mohan C ^b   Mathur, Neeraj ^a   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Biomarker; CYP1A1; Enzyme; Expression; Lung cancer; Lymphocyte

Indexed keywords

CYTOCHROME P450 1A1; ETHOXYRESORUFIN DEETHYLASE; MESSENGER RNA;

ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LUNG CANCER; LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SMOKING;

CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; GENE EXPRESSION; GENOTYPE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; POLYMORPHISM, GENETIC; RNA, MESSENGER; SMOKING;

NICOTIANA TABACUM;

EID: 70350031110     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.07.006     Document Type: Article

References (35)

1. Jiang J., Gelhaus S.L., Mangal D., Harvey R.G., Blair I.A., and Penning T.M. Metabolism of benzo(a)pyrene in human bronchoalveolar H358 cells using liquid chromatography-mass spectrometry. Chem. Res. Toxicol. 20 (2009) 1331-1341
2. Gonzalez F.J., and Kimura S. Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice. Mutat. Res. 477 (2001) 79-87
3. Thum T.E., Erpenbeck V.J., Moeller J., Hohfeld J.M., Krug N., and Borlak J. Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and non-smokers. Environ. Health Perspect. 114 (2006) 1655-1661
4. Kim J.H., Sherman M.E., Curriero F.C., Guengerich F.P., Strickland P.T., and Sutter T.R. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol. Appl. Pharmacol. 199 (2004) 210-219
5. Shimada T. Human cytochrome P450 1B1 and chemical carcinogenesis. Rev. Toxicol. 3 (2000) 139-166
6. Kellermann G., Lutyen-Kellermann M., and Shaw C.R. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet. 25 (1973) 327-331
7. Kouri R.E., McKinney C.E., Slomiany D.J., Snodgrass D.R., Wray N.P., and McLemore T.L. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 42 (1982) 5030-5037
8. Alexandrov K., Rojas M., Geneste O., Castegnaro M., Camus A.M., Petruzzelli S., Giuntini C., and Bartsch H. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 52 (1992) 6248-6253
9. Smith G.B., Harper P.A., Wong J.M., Lam M.S., Reid K.R., Petsikas D., and Massey T.E. Human lung microsomal cytochrome P450 1A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione-S-transferase M1 genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 839-853
10. Harris C.C., Autreep H., Connor R., Barrett L.A., Mc Dowell E.M., and Trump B.F. Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi. Science 194 (1976) 1067-1069
11. Vanden Heuvel J.P., Clark G.C., Thompson C.L., McCoy Z., Miller C.R., Lucier G.W., and Bell D.A. CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis 14 (1993) 2003-2006
12. Dey A., Parmar D., Dayal M., Dhawan A., and Seth P.K. Cytochrome P4501A1 (CYP1A1) in blood lymphocytes: evidence for catalytic activity and mRNA expression. Life Sci. 69 (2001) 383-393
13. Dey A., Parmar D., Dhawan A., Dash D., and Seth P.K. Cytochrome P4502E1 dependent catalytic activity and lipid peroxidation in rat blood lymphocytes. Life Sci. 71 (2002) 2509-2519
14. Dey A., Dhawan A., Seth P.K., and Parmar D. Evidence for cytochrome P450 2E1 catalytic activity and expression in rat blood lymphocytes. Life Sci. 77 (2005) 1082-1093
15. Landi M.T., Bertazzi P.A., Shields P.G., Clark G., Lucier G.W., Garte S.J., Cosma G., and Caporaso N.E. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4 (1994) 242-246
16. Crofts F., Taioli E., Trachman J., Cosma G.N., Currie D., Toniolo P., and Garte J. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15 (1994) 2961-2963
17. Shah P.P., Singh A.P., Singh M., Mathur N., Pant M.C., Mishra B.N., and Parmar D. Interaction of Cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat. Res. 639 (2008) 1-10
18. Patterson Jr. M.K. Measurement of growth and viability of cells in culture. In: Jakoby W.B., and Paston I.H. (Eds). Methods in Enzymology LV111 (1979), Academic Press Inc., California 141-151
19. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
21. Dohr O., Vogel C., and Abel J. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Arch. Biochem. Biophys. 321 (1995) 405-412
22. Kouri R.E., Imblum R.L., Sosnowski R.G., Slomiany D.J., and McKinney C.E. Parameters influencing quantitation of 3-methylcholanthrene-induced aryl hydrocarbon hydroxylase activity in cultured human lymphocytes. J. Environ. Pathol. Toxicol. 2 (1979) 1079-1098
23. Lin P., Hsueh Y.M., Ko J.L., Liang Y.F., Tsai K.J., and Chen C.Y. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer 40 (2003) 123-129
24. Cosma G.N., Toniolo P., Currie D., Pasternack B.S., and Garte S.J. Expression of the CYP1A1 gene in peripheral lymphocytes as a marker of exposure to creosote in railroad workers. Cancer Epidemiol. Biomarkers Prev. 1 (1992) 137-142
25. Omiecinski C.J., Hassett C., and Hosagrahara V. Epoxide hydrolase-polymorphism and role in toxicology. Toxicol. Lett. 15 (2000) 365-370
26. Whitlock J.P., Cooper Jr. H.L., and Gelboin V.H. Aryl hydrocarbon (benzopyrene) hydroxylase is stimulated in human lymphocytes by mitogens and benz (a) anthracene. Science 177 (1972) 618-619
27. Van Duursen M.B., Sanderson J.T., Van der Bruggen M., van der Linden J., and van den Berg M. Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. Toxicol. Appl. Pharmacol. 190 (2003) 241-250
28. McLemore T.L., Adelberg S., Liu M.C., McMahon N.A., Yu S.J., Hubbard W.C., Czerwinski M., et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst. 82 (1990) 1333-1339
29. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., and Autrup J.L. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1239-1248
30. Jacquet M., Lambert V., Baudoux E., Muller M., Kremers P., and Gielen J. Correlation between P450 CYP1A1 inducibility, Msp1 genotype and lung cancer incidence. Eur. J. Cancer 32A (1996) 1701-1706
31. Landi M., Bergen A., Baccarelli A., Patterson D., Grassman J., Ter-Minassian M., Mocarelli P., Caporaso N., Masten S., Pesatori A., Pittman G., and Bell D. CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from Seveso, Italy. Toxicology 207 (2005) 191-202
32. Cosma G., Crofts F., Taioli E., Toniolo P., and Garte S. Relationship between genotype and function of the human CYP1A1 gene. J. Toxicol. Environ. Health 40 (1993) 309-316
33. Saarikoski S.T., Voho A., Reinikainen M., Anttila S., Karjalainen A., Malaveille C., Vainio H., Husgafvel-Pursiainen K., and Hirvonen A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int. J. Cancer 77 (1998) 516-521
34. Cosma G.N., Crofts F., Currie D., Wirgin I., Toniolo P., and Garte S.J. Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiol. Biomarkers Prev. 2 (1993) 53-57
35. Butkiewicz D., Cole K.J., Phillips D.H., Harris C.C., and Chorazy M. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adducts levels. Eur. J. Cancer Prev. 8 (1999) 315-323